Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Sell
231,321
-8,286
-3% -$801K 0.17% 172
2026
Q1
$23.2M Buy
+239,607
New +$27.8M 0.19% 167

Other funds holding ESAB

Boston Trust Walden's ESAB Position: Q2 2026 in Review

Boston Trust Walden reduced its ESAB (ESAB) stake by 3.5% in Q2 2026, selling an estimated $801K and leaving 231,321 shares worth $22.8M. The position accounts for 0.17% of the portfolio, ranked #172.

Boston Trust Walden first reported a position in ESAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $23.2M in Q1 2026. 347 funds tracked by Wall St. Rank hold ESAB as of Q2 2026.

  • Boston Trust Walden held 231,321 shares of ESAB worth $22.8M as of Q2 2026.
  • Boston Trust Walden sold 8,286 ESAB shares in Q2 2026, an estimated $801K.
  • ESAB made up 0.17% of Boston Trust Walden's portfolio in Q2 2026, its #172 holding.
  • Boston Trust Walden first reported a position in ESAB in Q1 2026 and has held it in 2 quarters since.
  • Boston Trust Walden's ESAB position peaked at $23.2M in Q1 2026.
  • 347 funds tracked by Wall St. Rank held ESAB as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.